Neutrophils in patients with chronic coronary syndrome exhibit delayed apoptosis and resistance to regulatory T cell-induced apoptosis - Brief Report

This study reveals that patients with chronic coronary syndrome exhibit delayed neutrophil apoptosis and a pro-inflammatory phenotype that is resistant to regulatory T cell-induced apoptosis, suggesting that neutrophil dysfunction contributes to persistent inflammation in this condition.

The Gist

The Big Picture: A Traffic Jam in the Body's Cleanup Crew

Imagine your body is a busy city. When there's a minor accident (like a small infection or a scratch), the city sends out its cleanup crew: the neutrophils. These are white blood cells that rush to the scene, fight off the bad guys, and then, once the job is done, they are supposed to pack up and leave (a process called apoptosis, or programmed death).

In a healthy city, this cleanup crew works efficiently: they arrive, do their job, and then quietly exit the stage so the city can return to normal.

However, in patients with Chronic Coronary Syndrome (CCS)—a condition where the heart's arteries are narrowed but not currently blocked—the study found that this cleanup crew has a serious problem. They aren't just working hard; they are refusing to leave the party.

The Main Findings: The "Refusal to Quit"

1. The Cleanup Crew Won't Clock Out
In healthy people, neutrophils naturally die off after a few hours once they've done their job. But in patients with CCS, these cells are "immortal" in a bad way. They stay alive much longer than they should.

• The Analogy: Imagine a construction crew that finishes fixing a pothole but refuses to leave the street. They keep standing there, blocking traffic and causing more chaos. In the body, these "zombie" neutrophils keep releasing inflammatory chemicals, keeping the heart in a state of constant, low-level stress. This explains why inflammation persists in these patients even when they aren't having a heart attack.

2. The "Aged" and "Angry" Look
The study looked at the surface of these cells and found they looked "aged" and "activated."

• The Analogy: Healthy neutrophils are like fresh recruits. The neutrophils in CCS patients looked like grumpy, overworked veterans who have been on the job too long. They were wearing "battle gear" (markers like CD66b and CXCR4) that signaled they were ready to fight, even when there was no active battle.

3. The Broken "Off-Switch" (The T-Reg Problem)
This is the most fascinating part of the study. The body has a special type of police officer called Regulatory T cells (Tregs). Their job is to tell the cleanup crew (neutrophils), "Okay, the job is done, go home and rest."

• In Healthy People: When Tregs meet neutrophils, they shake hands (cell-to-cell contact) and successfully tell the neutrophils to die off.
• In CCS Patients: The Tregs tried to do their job, but the neutrophils ignored them. The "off-switch" was broken. The neutrophils were so stubborn that the Tregs couldn't force them to leave.
• The Discovery: The researchers found that this "handshake" (direct physical contact) is essential. If you put a wall between the Tregs and the neutrophils (using a mesh), the Tregs couldn't tell them to die, even in healthy people. But in CCS patients, even when they were in the same room, the Tregs failed to get the message across.

Why Does This Matter?

For a long time, doctors have treated heart disease by lowering cholesterol and blood pressure. But many patients still have heart issues because of hidden inflammation.

This study suggests that the root of the problem might be this "stubborn" cleanup crew. Because the neutrophils won't die and won't listen to the Tregs, they keep the heart arteries inflamed, making it harder for the heart to heal and easier for new blockages to form.

The Takeaway

Think of the heart as a house that needs to stay clean.

• The Problem: The janitors (neutrophils) are staying in the house long after the mess is cleaned up, making a mess of their own.
• The Broken System: The manager (Tregs) tries to fire them, but the janitors refuse to listen.
• The Future: Instead of just mopping the floor (lowering cholesterol), future treatments might need to focus on forcing the janitors to clock out or fixing the manager's ability to give orders.

This research opens a new door for treating heart disease by targeting the immune system's "cleanup crew" to help the body finally resolve its inflammation.

Technical Summary

1. Problem Statement

Persistent low-grade inflammation is a critical driver of recurrent cardiovascular events in patients with Chronic Coronary Syndrome (CCS), even when classical risk factors are managed. While the role of neutrophils in acute coronary syndrome (ACS) is well-established, their behavior in the stabilized phase of CCS remains unclear.

• The Gap: It is unknown whether neutrophils in CCS patients exhibit delayed apoptosis (a mechanism for resolving inflammation) and whether this is linked to the known deficiency or dysfunction of Regulatory T cells (Tregs) in these patients.
• Hypothesis: The authors hypothesized that CCS patients exhibit delayed neutrophil apoptosis and that this persistence is driven by a failure of Tregs to induce neutrophil death, contributing to a non-resolved inflammatory state.

2. Methodology

The study employed an ex vivo approach comparing 20 patients with CCS (clinically stable, median 11.5 months post-ACS) against 19 age- and sex-matched healthy controls (HC).

• Cell Isolation:
  • Neutrophils: Isolated from whole blood using Polymorphprep.
  • Tregs: Isolated from PBMCs as CD4+CD25+CD127-/low cells.
  • CD4+ T cells: Isolated as a control population.
• Experimental Conditions:
  • Stimuli: Cells were cultured for 2.5h or 5h with or without:
    • Anti-inflammatory: IL-10 (20 ng/ml).
    • Pro-inflammatory: TNF (1 ng/ml) or LPS (100 ng/ml).
  • Co-cultures: Neutrophils were co-cultured with autologous Tregs at varying ratios (10:1, 4:1, 1:1) to assess Treg-mediated regulation.
  • Transwell Assays: Used to physically separate Tregs and neutrophils via a membrane to determine if cell-to-cell contact is required for apoptosis induction.
• Readouts:
  • Apoptosis: Measured via flow cytometry using Annexin V and SYTOX Red (Annexin+/SYTOX- = early apoptosis).
  • Phenotype: Surface expression of CD66b (activation) and CXCR4 (aging) via flow cytometry.
  • Secretome: Supernatants analyzed via Luminex/Olink for granule proteins (MMP-8, MMP-9, MPO) and cytokines (TNF, IL-6, IL-1β, IFN-γ, IL-18).
• Statistical Analysis: Mann-Whitney U test for group comparisons; Wilcoxon signed-rank for paired data; Greenhouse-Geisser for concentration dependency.

3. Key Contributions

This study provides novel mechanistic insights into the pathophysiology of CCS by:

1. Establishing a link between Treg dysfunction and neutrophil persistence: It demonstrates that the failure to clear neutrophils in CCS is not just due to intrinsic neutrophil defects but specifically due to a loss of Treg-mediated apoptotic signaling.
2. Defining the mechanism of Treg action: The study clarifies that Treg-induced neutrophil apoptosis is contact-dependent and not mediated by IL-10 secretion in this context.
3. Characterizing the "Aged" Neutrophil Phenotype: It identifies that CCS neutrophils are not only delayed in dying but are also "aged" (high CXCR4) and hyper-reactive (high CD66b), suggesting a distinct pro-inflammatory subset accumulates in chronic disease.

4. Key Results

• Delayed Spontaneous Apoptosis:

  • Neutrophils from CCS patients showed significantly lower spontaneous apoptosis after 5 hours compared to controls (10.3% vs. 19.2%, p=0.025).
  • This delay persisted even in the presence of IL-10 but was less distinct under strong inflammatory stimulation (TNF/LPS).

• Pro-inflammatory and Aged Phenotype:

  • Activation: CCS neutrophils exhibited significantly higher surface expression of CD66b (activation marker) both immediately after isolation and after 5h culture.
  • Aging: CCS neutrophils showed increased CXCR4 expression, indicating an accumulation of senescent/aged neutrophils in circulation.
  • Hyper-reactivity: Upon LPS stimulation, CCS neutrophils secreted significantly higher levels of MMP-9, MMP-8, TNF, IFN-γ, IL-6, and IL-1β compared to controls.

• Treg-Mediated Apoptosis Failure:

  • In Healthy Controls: Autologous Tregs induced a concentration-dependent increase in neutrophil apoptosis.
  • In CCS Patients: Tregs failed to induce neutrophil apoptosis at any ratio, indicating a specific resistance of CCS neutrophils to Treg regulation.
  • Mechanism:
    • IL-10 Independence: Adding exogenous IL-10 did not induce apoptosis, and Treg co-cultures produced negligible IL-10.
    • Contact Dependence: Transwell experiments (separating cells) completely abrogated Treg-induced apoptosis in healthy controls, proving that direct cell-to-cell contact is the essential mechanism.

• Treg Viability: Treg survival and CD4+ T cell survival were comparable between groups, ruling out Treg death as the cause of the regulatory failure.

5. Significance and Implications

• Pathophysiological Insight: The findings suggest that the persistent inflammation in CCS is driven by a "double hit": neutrophils are intrinsically resistant to apoptosis and are no longer susceptible to the "braking" mechanism of Tregs. This leads to an accumulation of aged, hyper-reactive neutrophils that continuously release tissue-damaging enzymes (MMPs) and cytokines.
• Therapeutic Target: Despite optimal medical therapy (including statins), this neutrophil dysfunction persists. The study proposes neutrophil apoptosis as a novel therapeutic target. Restoring the ability of Tregs to induce neutrophil death (potentially via contact-dependent pathways) could resolve the chronic inflammatory state in CCS.
• Clinical Context: The study highlights that this dysfunction exists in clinically stable patients, suggesting that current guidelines focusing solely on lipid lowering and blood pressure may not address the underlying immunological drivers of residual risk.

Limitations Noted by Authors: Small sample size (n=20/19), in vitro co-culture ratios (1:1 to 10:1) do not reflect physiological blood ratios (approx. 100:1), and lack of deep phenotyping of the Tregs themselves. However, the study successfully bridges epidemiological data with mechanistic ex vivo human biology.